CPEB3 selectively inhibits α‐synuclein aggregation without modulating TDP ‐43 pathology
FEBS Letters · 2026-07 · 600 (14) · 2012-2027
DOI: 10.1002/1873-3468.70308 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Letters, online erschienen am 24.02.2026. Verfasst von Ann Teres Babu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), Thiruvananthapuram, India. Hauptthemen laut MEDLINE: alpha-Synuclein, DNA-Binding Proteins, RNA-Binding Proteins, Protein Aggregates. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Scheme for Transformational and Advanced Research in Sciences (STARS), Ministry of Education, Government of India.
Abstract (Originalsprache)
Abnormal accumulation of misfolded proteins is a hallmark of neurodegenerative diseases. Amyloid aggregation of α‐synuclein (α‐Syn) and TAR DNA‐binding protein 43 (TDP‐43) contributes to Parkinson's disease and frontotemporal dementia, respectively. The heterotypic aggregates are increasingly recognized as highly cytotoxic. Given the frequent co‐occurrence of α‐Syn, TDP‐43, and tau pathologies, we examined whether the first prion‐like domain (PRD1) of CPEB3 modulates α‐Syn and TDP‐43 aggregation. Nuclear magnetic resonance (NMR) relaxation experiments revealed a direct interaction between PRD1 and the amyloid core of α‐Syn, suppressing its aggregation, while phase separation assays showed delayed liquid–liquid phase separation (LLPS) ‐mediated α‐Syn aggregation. In contrast, no interaction was detected with the C‐terminal domain of TDP‐43 (TDP‐43 CTD ), indicating selective inhibition of α‐Syn aggregation by PRD1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), Thiruvananthapuram, India.
ORCID-Profile: Vinesh Vijayan
Förderung
- Scheme for Transformational and Advanced Research in Sciences (STARS), Ministry of Education, Government of India
Zitieren
APA
Babu, A. T., A, M. F., Periasamy, H. V., & Vijayan, V. (2026). CPEB3 selectively inhibits α‐synuclein aggregation without modulating TDP ‐43 pathology. FEBS Letters, 600(14), 2012-2027. https://doi.org/10.1002/1873-3468.70308
Vancouver
Babu AT, A MF, Periasamy HV, Vijayan V. CPEB3 selectively inhibits α‐synuclein aggregation without modulating TDP ‐43 pathology. FEBS Letters. 2026;600(14):2012-2027. doi:10.1002/1873-3468.70308
BibTeX
@article{Babu2026,
author = {Babu, Ann Teres and A, Mufeeda Farhana and Periasamy, Harsha Varthini and Vijayan, Vinesh},
title = {CPEB3 selectively inhibits α‐synuclein aggregation without modulating TDP ‐43 pathology},
journal = {FEBS Letters},
year = {2026},
volume = {600},
number = {14},
pages = {2012--2027},
doi = {10.1002/1873-3468.70308}
}
EUVIMED